Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Price Institute of Surgical Research, University of Louisville; and Noveratech LLC of Louisville, Louisville, KY, USA.
Lasers Med Sci. 2022 Sep;37(7):2805-2815. doi: 10.1007/s10103-022-03581-5. Epub 2022 May 30.
This review aims to providing essential information and the current knowledge about the potential role of macrophages, especially their M2 subtypes in different diabetic wounds both in clinical and pre-clinical models under the influence of photobiomodulation (PBM). The long-term goal is to advance the macrophage-based therapies to accelerate healing of diabetic foot ulcers. We reviewed all databases provided by PubMed, Google Scholar, Scopus, Web of Science, and Cochrane precisely from their dates of inception to 25/10/2021. The keywords of Diabetes mellitus diseases, wound healing, macrophage, and photobiomodulation or low-level laser therapy were used in this systematic review.A total of 438 articles were initially identified in pubmed.ncbi.nlm.nih.gov (15 articles), Google scholar (398 articles), Scopus (18 articles), and Web of Science (7 articles). Four hundred sixteen articles that remained after duplicate studies (22 articles) were excluded. After screening abstracts and full texts, 14 articles were included in our analysis. Among them, 4 articles were about the effect of PBM on macrophages in type 2 diabetes and also found 10 articles about the impact of PBM on macrophages in type 1 diabetes. The obtained data from most of the reviewed studies affirmed that the PBM alone or combined with other agents (e.g., stem cells) could moderate the inflammatory response and accelerate the wound healing process in pre-clinical diabetic wound models. However, only very few studies conducted the detailed functions of polarized macrophages and M2 subtypes in wound healing of diabetic models under the influence of PBM. Further pre-clinical and clinical investigations are still needed to investigate the role of M2 macrophages, especially its M2c subtype, in the healing processes of diabetic foot ulcers in clinical and preclinical settings.
这篇综述旨在提供有关巨噬细胞(尤其是其 M2 亚型)在不同糖尿病创面中潜在作用的基本信息和当前知识,这些创面分别来自临床和临床前模型,同时还受到光生物调节(PBM)的影响。其长期目标是推进基于巨噬细胞的疗法,以加速糖尿病足溃疡的愈合。我们系统地检索了 PubMed、Google Scholar、Scopus、Web of Science 和 Cochrane 中所有数据库,检索时间均从建库开始到 2021 年 10 月 25 日。本综述使用了“糖尿病疾病、伤口愈合、巨噬细胞和光生物调节或低水平激光治疗”等关键词。
最初在 pubmed.ncbi.nlm.nih.gov(15 篇文章)、Google Scholar(398 篇文章)、Scopus(18 篇文章)和 Web of Science(7 篇文章)中确定了 438 篇文章。经过去除重复研究(22 篇文章)后,仍有 416 篇文章。经过筛选摘要和全文,我们共纳入 14 篇文章进行分析。其中,4 篇文章探讨了 PBM 对 2 型糖尿病巨噬细胞的影响,还有 10 篇文章探讨了 PBM 对 1 型糖尿病巨噬细胞的影响。大多数综述研究的数据都证实,PBM 单独或与其他药物(如干细胞)联合使用,可以调节炎症反应,加速临床前糖尿病创面模型的愈合过程。然而,只有极少数研究详细研究了 PBM 影响下糖尿病模型中极化巨噬细胞和 M2 亚型的功能。仍需要进一步的临床前和临床研究来探究 M2 巨噬细胞,尤其是其 M2c 亚型,在临床和临床前环境下糖尿病足溃疡愈合过程中的作用。